- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 305/08 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
Patent holdings for IPC class C07D 305/08
Total number of patents in this class: 273
10-year publication summary
33
|
23
|
31
|
24
|
24
|
26
|
25
|
31
|
24
|
8
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Corsair Pharma, Inc. | 36 |
13 |
Sitryx Therapeutics Limited | 36 |
10 |
Bristol-myers Squibb Company | 4848 |
8 |
Corteva Agriscience LLC | 2641 |
8 |
Hangzhou Phecdamed Co., Ltd. | 12 |
6 |
Genentech, Inc. | 3888 |
5 |
Syngenta Crop Protection AG | 5827 |
5 |
Bayer Cropscience AG | 2087 |
5 |
AbbVie Deutschland GmbH & Co. KG | 259 |
5 |
Cytokinetics, Inc. | 267 |
5 |
Novomer, Inc. | 210 |
5 |
Hoffmann-La Roche Inc. | 3341 |
4 |
BASF SE | 20570 |
4 |
Biogen MA Inc. | 884 |
4 |
Canopy Growth Corporation | 219 |
4 |
Iowa State University Research Foundation, Inc. | 750 |
4 |
Taisho Pharmaceutical Co., Ltd. | 847 |
4 |
Toyama Chemical Co., Ltd. | 103 |
4 |
Xenon Pharmaceuticals Inc. | 196 |
4 |
Fgh Biotech, Inc. | 13 |
4 |
Other owners | 162 |